Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.53 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.53 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 3/20 | 0.46 |
| ▸ | PPARG | P37231 | 2/20 | 0.44 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28585490 | 1.00 | FFAR1 (0.53) | FFAR1FFAR4GPR84MEN1CYP3A4 | |
| SCHEMBL2145696 | 1.00 | FFAR1 (0.53) | FFAR1FFAR4GPR84MEN1CYP3A4 | |
| SCHEMBL6015976 | 1.00 | FFAR1 (0.53) | FFAR1FFAR4GPR84MEN1CYP3A4 | |
| SCHEMBL31197028 | 0.98 | FFAR1 (0.51) | FFAR1FFAR4GPR84MEN1CYP3A4 | |
| SCHEMBL21552054 | 0.92 | FFAR1 (0.45) | FFAR1FFAR4GPR84MEN1CYP3A4 | |
| SCHEMBL21552055 | 0.92 | FFAR1 (0.45) | FFAR1FFAR4GPR84MEN1CYP3A4 | |
| SCHEMBL10081525 | 0.90 | FFAR1 (0.62) | FFAR1FFAR4GPR84MEN1CYP3A4 | |
| SCHEMBL2826342 | 0.90 | FFAR1 (0.62) | FFAR1FFAR4GPR84MEN1CYP3A4 | |
| SCHEMBL3185051 | 0.90 | FFAR1 (0.62) | FFAR1FFAR4GPR84MEN1CYP3A4 | |
| SCHEMBL17744144 | 0.90 | FFAR1 (0.62) | FFAR1FFAR4GPR84MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2854759-A1 | DOSAGE FORMS COMPRISING APIXABAN AND MATRIX FORMER | ratiopharm GmbH (DE) | 2015-04-08 | — | — | EP | disclosed |
| WO-2013174498-A1 | DOSAGE FORMS COMPRISING APIXABAN AND MATRIX FORMER | RATIOPHARM GMBH (DE) | 2013-11-28 | — | — | WO | disclosed |